<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="used to slow or treat COVID-19 disease. Here, we suggest" exact="melatonin" post="be given consideration for prophylactic use or treatment alone"/>
 <result pre="increased age. Under the current critical conditions, large doses of" exact="melatonin" post="alone or in combination with currently-recommended drugs, e.g., hydroxychloroquine/chloroquine,"/>
 <result pre="drugs, e.g., hydroxychloroquine/chloroquine, to resist COVID-19 infection would seem judicious." exact="melatonin" post="COVID-19 SARS-CoV-2 treatment-drug prevention &amp;amp; control Funding FundaciÃƒÂ³n Canaria"/>
 <result pre="a clinical trial called SOLIDARITY to investigate 4 potential treatments:" exact="lopinavir" post="and ritonavir plus interferon-beta, lopinavir and ritonavir, chloroquine/hydroxychloroquine, and"/>
 <result pre="trial called SOLIDARITY to investigate 4 potential treatments: lopinavir and" exact="ritonavir" post="plus interferon-beta, lopinavir and ritonavir, chloroquine/hydroxychloroquine, and remdesivir (7)."/>
 <result pre="to investigate 4 potential treatments: lopinavir and ritonavir plus interferon-beta," exact="lopinavir" post="and ritonavir, chloroquine/hydroxychloroquine, and remdesivir (7). The medical profession"/>
 <result pre="for a cheap, viable, and readily available treatment such as" exact="melatonin" post="(8). Melatonin is synthesized from tryptophan in the pineal"/>
 <result pre="associated with mitochondria. It is noteworthy that high levels of" exact="melatonin" post="play positive roles in health and aging. Melatonin, a"/>
 <result pre="Herein, we review the current evidence for a role of" exact="melatonin" post="as a COVID-19 treatment. Since the clinical data is"/>
 <result pre="clinical data is very limited, we propose the use of" exact="melatonin" post="in patients with COVID-19 to reduce morbidity and mortality."/>
 <result pre="even of non-infected cells (13). COVID-19 infection may attack the" exact="melatonin" post="synthetic pathway resulting in reduced melatonin levels at a"/>
 <result pre="infection may attack the melatonin synthetic pathway resulting in reduced" exact="melatonin" post="levels at a time when melatonin is most needed"/>
 <result pre="pathway resulting in reduced melatonin levels at a time when" exact="melatonin" post="is most needed (14). The uncontrolled innate immune response"/>
 <result pre="16). The pineal gland produces and maintains the concentration of" exact="melatonin" post="in the blood. The melatonin synthesized in the pineal"/>
 <result pre="and maintains the concentration of melatonin in the blood. The" exact="melatonin" post="synthesized in the pineal gland is &amp;lt;5% of the"/>
 <result pre="synthesized in the pineal gland is &amp;lt;5% of the total" exact="melatonin" post="produced. The melatonin produced in the mitochondria is not"/>
 <result pre="pineal gland is &amp;lt;5% of the total melatonin produced. The" exact="melatonin" post="produced in the mitochondria is not discharged into the"/>
 <result pre="it (15). If patients do not generate sufficient amounts of" exact="melatonin" post="their health status is likely compromised (16). Autophagy plays"/>
 <result pre="different stages of the viral life cycle. The fact that" exact="melatonin" post="is a regulator of autophagy due to its properties"/>
 <result pre="human papilloma, and inter alia, have demonstrated the success of" exact="melatonin" post="in protecting against viral infections. There is no evidence"/>
 <result pre="in protecting against viral infections. There is no evidence that" exact="melatonin" post="is viricidal but rather it reduces the severity of"/>
 <result pre="this disease. Melatonin, the Elderly &amp;amp; COVID-19 A relationship between" exact="melatonin" post="and aging has been suggested, due to a decrease"/>
 <result pre="suggested, due to a decrease in the concentration of nocturnal" exact="melatonin" post="levels in the elderly (23). It has been hypothesized"/>
 <result pre="levels in the elderly (23). It has been hypothesized that" exact="melatonin" post="can prolong life (24). The relationship of melatonin with"/>
 <result pre="hypothesized that melatonin can prolong life (24). The relationship of" exact="melatonin" post="with aging involves three potential mechanisms: first, melatonin is"/>
 <result pre="relationship of melatonin with aging involves three potential mechanisms: first," exact="melatonin" post="is a key molecule in regular circadian rhythms (25);"/>
 <result pre="is a key molecule in regular circadian rhythms (25); second," exact="melatonin" post="prevents cardiolipin peroxidation and regulates the synthesis of mitochondrial"/>
 <result pre="peroxidation and regulates the synthesis of mitochondrial proteins (26); finally," exact="melatonin" post="secreted by leukocytes exerts a powerful immunomodulatory function (24)."/>
 <result pre="COVID-19 (25). Recent studies have shown that high levels of" exact="melatonin" post="in the blood play a positive role in health"/>
 <result pre="health and aging (27). These findings support a rationale for" exact="melatonin" post="use in elderly suffering with COVID-19. Melatonin, Medical Comorbidities"/>
 <result pre="HEIJO-KYO cohort (cohort of elderly Japanese patients), urinary excretion of" exact="melatonin" post="was associated with reduced nocturnal systolic blood pressure, independent"/>
 <result pre="other cardiovascular risk factors. More precisely, an increase in urinary" exact="melatonin" post="excretion from 4.2 to 10.5 Î¼g caused a 2"/>
 <result pre="mmHg decrease in nocturnal systolic blood pressure. Patients who took" exact="melatonin" post="at a dose of 2â€&quot;5 mg/day for 7â€&quot;90 days"/>
 <result pre="is a risk factor for cardiovascular disease. In different studies," exact="melatonin" post="has been shown to have anti-obesity effects (30, 31)."/>
 <result pre="has been shown to have anti-obesity effects (30, 31). Taking" exact="melatonin" post="reduces intra-abdominal visceral fat deposition and body weight. Its"/>
 <result pre="melatonin, showing that diabetic subjects have a lower concentration of" exact="melatonin" post="(33). Furthermore, decreased blood melatonin levels have been documented"/>
 <result pre="have a lower concentration of melatonin (33). Furthermore, decreased blood" exact="melatonin" post="levels have been documented in patients with insulin resistance"/>
 <result pre="intolerance (34). The results of several studies suggest that low" exact="melatonin" post="production is associated with an increased risk of cardiovascular"/>
 <result pre="prognosis for patients with COVID-19. Published reports routinely show that" exact="melatonin" post="reduces the consequences of the comorbidities in patients with"/>
 <result pre="Prevention in the Population (Elderly &amp;amp; Medical Comorbidities) While physiological" exact="melatonin" post="concentrations in biological fluids oscillate between 10âˆ’10 and 10âˆ’11"/>
 <result pre="justifying the need of a more generous supplementation of exogenous" exact="melatonin" post="in life-threatening pathologies. Oral melatonin use by humans is"/>
 <result pre="more generous supplementation of exogenous melatonin in life-threatening pathologies. Oral" exact="melatonin" post="use by humans is generally considered safe, with minor"/>
 <result pre="headache, drowsiness, etc. (43). To date, the best dose of" exact="melatonin" post="in older adults has not been determined, as its"/>
 <result pre="some of which were not blinded, the efficacy of oral" exact="melatonin" post="administration (1â€&quot;20 mg) was evaluated caused only a few"/>
 <result pre="drowsiness (45). In elderly patients with medical comorbidities, treatment with" exact="melatonin" post="is beneficial, as it strengthens the immune response. We"/>
 <result pre="bedtime to better simulate the normal physiological circadian rhythm of" exact="melatonin" post="(Figure 1). Furthermore, it may be beneficial in people"/>
 <result pre="contracting COVID-19 infection, local health workers, where preventive treatment with" exact="melatonin" post="would favor maximizing the immune response, along with anti-inflammatory"/>
 <result pre="the clinical features parallel those of COVID-19 viral infection; moreover," exact="melatonin" post="has been demonstrated to relieve many of the symptoms"/>
 <result pre="situation and in consideration of evidence-based medicine, the efficacy of" exact="melatonin" post="and its high pharmacological safety profile supports its use"/>
 <result pre="Our research group has extensive experience in the use of" exact="melatonin" post="in the context of cardiovascular physiology. Melatonin can be"/>
 <result pre="years ago in which he gave humans one gram of" exact="melatonin" post="daily for a month with no untoward effect. Melatonin"/>
 <result pre="no time or clinical trials to test the efficacy of" exact="melatonin" post="at different concentrations, we suggest the use of melatonin"/>
 <result pre="of melatonin at different concentrations, we suggest the use of" exact="melatonin" post="(100 or 400 mg per day) as an adjunct,"/>
 <result pre="available (Figure 2). Figure 2 Therapeutic algorithm for use of" exact="melatonin" post="in patients with COVID-19. Melatonin will likely reduce the"/>
 <result pre="patients with COVID-19. Melatonin will likely reduce the toxicity of" exact="chloroquine" post="and increase its efficacy. BID, twice daily; PO, per"/>
 <result pre="(51) and Zhang et al. (8), support the use of" exact="melatonin" post="in patients with COVID-19. We agree with the suggestion"/>
 <result pre="COVID-19. We agree with the suggestion by those authors that" exact="melatonin" post="should be given consideration for prophylactic use or treatment"/>
 <result pre="16.SedovaKABernikovaOGCuprovaJIIvanovaADKutaevaGAPlissMGet al.. Association between antiarrhythmic, electrophysiological, and antioxidative effects of" exact="melatonin" post="in ischemia/reperfusion. Int J Mol Sci. (2019) 20:E6331. 10.3390/ijms2024633131847485"/>
 <result pre="Mol Sci. (2019) 20:E6331. 10.3390/ijms2024633131847485 17.BogaJACaballeroBPotesYPerez-MartinezZReiterRJVega-NaredoIet al.. Therapeutic potential of" exact="melatonin" post="related to its role as an autophagy regulator: a"/>
 <result pre="review. J Pineal Res. (2019) 66:e12534. 10.1111/jpi.1253430329173 18.AndersonGMaesMMarkusRPRodriguezM. Ebola virus:" exact="melatonin" post="as a readily available treatment option. J Med Virol."/>
 <result pre="Med Virol. (2015) 87:537â€&quot;43. 10.1002/jmv.2413025611054 19.PaemaneeAHitakarunARoytrakulSSmithDR. Screening of melatonin, Î±-tocopherol," exact="folic acid," post="acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity. BMC"/>
 <result pre="ahead of print]. 32220033 26.MajidiniaMReiterRJShakouriSKMohebbiIRastegarMKavianiMet al.. The multiple functions of" exact="melatonin" post="in regenerative medicine. Ageing Res Rev. (2018) 45:33â€&quot;52. 10.1016/j.arr.2018.04.00329630951"/>
 <result pre="mechanisms. J Pineal Res. (2013) 55:325â€&quot;56. 10.1111/jpi.1209024112071 28.ObayashiKSaekiKToneNKurumataniN. Relationship between" exact="melatonin" post="secretion and nighttime blood pressure in elderly individuals with"/>
 <result pre="meta-analyses. Br J Clin Pharmacol. (2017) 83:163â€&quot;71. 10.1111/bcp.1290226852373 30.GubinDGGubinGDGaponLIWeinertD. Daily" exact="melatonin" post="administration attenuates age-dependent disturbances of cardiovascular rhythms. Curr Aging"/>
 <result pre="cardiovascular rhythms. Curr Aging Sci. (2016) 9:5â€&quot;13. 10.2174/187460980966615113022001126632428 31.ImenshahidiMKarimiGHosseinzadehHEffects of" exact="melatonin" post="on cardiovascular risk factors and metabolic syndrome: a comprehensive"/>
 <result pre="Naunyn SchmiedebergsArch Pharmacol. (2020) 393:521â€&quot;36. 10.1007/s00210-020-01822-4 32.PradoNJFerderLManuchaWDiezER. Anti-inflammatory effects of" exact="melatonin" post="in obesity and hypertension. Curr Hypertens Rep. (2018) 20:45."/>
 <result pre="10.1016/j.ijcard.2016.07.05627404706 36.Dominguez-RodriguezAAbreu-GonzalezPde la Torre-HernandezJMConsuegra-SanchezLPiccoloRGonzalez-GonzalezJet al.. Usefulness of early treatment with" exact="melatonin" post="to reduce infarct size in patients with ST-segment elevation"/>
 <result pre="ST-segment elevation myocardial infarction receiving percutaneous coronary intervention (from the" exact="melatonin" post="adjunct in the acute myocardial infarction treated with angioplasty"/>
 <result pre="10.1016/S0735-1097(17)34668-528645475 37.Dominguez-RodriguezAAbreu-GonzalezPde la Torre-HernandezJMGonzalez-GonzalezJGarcia-CamareroTConsuegra-SanchezLet al.. Effect of intravenous and intracoronary" exact="melatonin" post="as an adjunct to primary percutaneous coronary intervention for"/>
 <result pre="coronary intervention for acute ST-elevation myocardial infarction: results of the" exact="melatonin" post="adjunct in the acute myocardial infarction treated with angioplasty"/>
 <result pre="ahead of print]. 22546772 42.NogueiraLMSampsonJNChuLWYuKAndrioleGChurchTet al.. Individual variations in serum" exact="melatonin" post="levels through time: implications for epidemiologic studies. PLoS ONE."/>
 <result pre="12 (Suppl 1):S54â€&quot;S65. 10.21037/jtd.2019.12.8532148926 44.VuralEMvan MunsterBCde RooijSE. Optimal dosages for" exact="melatonin" post="supplementation therapy in older adults: a systematic review of"/>
 <result pre="Cell Discov. (2020) 6:14. 10.1038/s41421-020-0153-332194980 49.NordlundJJLernerAB. The effects of oral" exact="melatonin" post="on skin color and on the release of pituitary"/>
</results>
